跳至主要内容
临床试验/CTRI/2018/08/015223
CTRI/2018/08/015223尚未招募3 期

Role of intrathecal nalbuphine on prevention of postspinal shivering after TURP

INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCESPATNA0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients of ASA physical status ! and 2.
  • 2.Patients between 20-60 years of age.
  • 3.Patients able to comprehend and willing to participate.
  • 4.Patient in whom nalbuphine is indicated for prevention of shivering.

排除标准

  • 1.Patients refusal to participate.
  • 2.Contraindication to use of nalbuphine
  • 3.Patient with known allergic to nalbuphine and bupivacaine.
  • 4.Patient contraindicated to regional anaesthesia.
  • 5.Obese patient with Body Mass Index (BMI >30).

研究者

发起方
INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCESPATNA

相似试验